BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 16906107)

  • 21. A review of the oral direct thrombin inhibitor ximelagatran: not yet the end of the warfarin era..
    Mohapatra R; Tran M; Gore JM; Spencer FA
    Am Heart J; 2005 Jul; 150(1):19-26. PubMed ID: 16084146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).
    Turpie AG; Bauer KA; Davidson BL; Fisher WD; Gent M; Huo MH; Sinha U; Gretler DD;
    Thromb Haemost; 2009 Jan; 101(1):68-76. PubMed ID: 19132191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The John Charnley Award. Natural history of thromboembolic disease after total hip arthroplasty.
    Pellegrini VD; Clement D; Lush-Ehmann C; Keller GS; Evarts CM
    Clin Orthop Relat Res; 1996 Dec; (333):27-40. PubMed ID: 8981880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective comparison of warfarin to aspirin for thromboprophylaxis in total hip and total knee arthroplasty.
    Intermountain Joint Replacement Center Writing Committee
    J Arthroplasty; 2012 Jan; 27(1):1-9.e2. PubMed ID: 21621959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extended travel after hip arthroplasty surgery. Is it safe?
    Ball ST; Pinsorsnak P; Amstutz HC; Schmalzried TP
    J Arthroplasty; 2007 Sep; 22(6 Suppl 2):29-32. PubMed ID: 17823011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of deep venous thrombosis prophylaxis in low-risk patients undergoing total knee arthroplasty.
    Callaghan JJ; Warth LC; Hoballah JJ; Liu SS; Wells CW
    J Arthroplasty; 2008 Sep; 23(6 Suppl 1):20-4. PubMed ID: 18722299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticoagulation therapy with heparin and warfarin in total knee arthroplasty for osteoarthritis knee.
    Kimura K; Ohtani S; Okamura H; Ishii N; Kishimoto C; Konishi K
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):109-12. PubMed ID: 19150995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty.
    Westrich GH; Bottner F; Windsor RE; Laskin RS; Haas SB; Sculco TP
    J Arthroplasty; 2006 Sep; 21(6 Suppl 2):139-43. PubMed ID: 16950076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of combined modality prophylaxis including short-duration warfarin to prevent venous thromboembolism after total hip arthroplasty.
    Keeney JA; Clohisy JC; Curry MC; Maloney WJ
    J Arthroplasty; 2006 Jun; 21(4):469-75. PubMed ID: 16781396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial.
    Francis CW; Davidson BL; Berkowitz SD; Lotke PA; Ginsberg JS; Lieberman JR; Webster AK; Whipple JP; Peters GR; Colwell CW
    Ann Intern Med; 2002 Oct; 137(8):648-55. PubMed ID: 12379064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. APC-resistance is a risk factor for postoperative thromboembolism in elective replacement of the hip or knee--a prospective study.
    Lindahl TL; Lundahl TH; Nilsson L; Andersson CA
    Thromb Haemost; 1999 Jan; 81(1):18-21. PubMed ID: 10348713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.
    Abad JI; Gómez-Outes A; Martínez-González J; Rocha E;
    Arch Orthop Trauma Surg; 2007 Oct; 127(8):665-70. PubMed ID: 17089172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors leading to decreased rates of deep vein thrombosis and pulmonary embolism after total knee arthroplasty.
    Kim YH; Yoo JH; Kim JS
    J Arthroplasty; 2007 Oct; 22(7):974-80. PubMed ID: 17920468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Venous thromboembolism after a total hip arthroplasty: prevention and treatment.
    Berry DJ
    Instr Course Lect; 2003; 52():275-80. PubMed ID: 12690855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevention of postoperative deep venous thrombosis in lower limb after operation by intermittent pneumatic compression].
    Lu WJ; Yu NS; Lin ZX
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2000 May; 14(3):129-31. PubMed ID: 12080845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Venous thromboembolism is rare with a multimodal prophylaxis protocol after total hip arthroplasty.
    González Della Valle A; Serota A; Go G; Sorriaux G; Sculco TP; Sharrock NE; Salvati EA
    Clin Orthop Relat Res; 2006 Mar; 444():146-53. PubMed ID: 16446593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Warfarin prophylaxis after total knee arthroplasty.
    Lieberman JR
    Am J Knee Surg; 1999; 12(1):49-53. PubMed ID: 10050694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty.
    White RH; Gettner S; Newman JM; Trauner KB; Romano PS
    N Engl J Med; 2000 Dec; 343(24):1758-64. PubMed ID: 11114314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after total hip or knee replacement. A randomized, double-blind, placebo-controlled trial.
    Heit JA; Elliott CG; Trowbridge AA; Morrey BF; Gent M; Hirsh J
    Ann Intern Med; 2000 Jun; 132(11):853-61. PubMed ID: 10836911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Warfarin prophylaxis and venous thromboembolism in the first 5 days following hip and knee arthroplasty.
    Brotman DJ; Jaffer AK; Hurbanek JG; Morra N
    Thromb Haemost; 2004 Nov; 92(5):1012-7. PubMed ID: 15543328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.